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Summary
a 17-year-old man with no significant past medical 
history presented with a 2-week history of worsening 
jaundice, lethargy, anorexia and progressive right upper 
quadrant abdominal pain. there were no stigmata 
of chronic liver disease. Initial investigations were 
suggestive of cholangitis with large intrahepatic and 
extrahepatic bile duct strictures but otherwise normal 
hepatic and splenic appearances. a percutaneous 
transhepatic cholangiogram with the positioning of 
drains was performed to alleviate the obstructive 
jaundice. Within 2 weeks of the first presentation, 
full blood count revealed a significantly raised white 
blood count and a subsequent peripheral blood smear 
and bone marrow were consistent with a diagnosis of 
acute myeloid leukaemia. Chemotherapy was started 
after partial improvement of his obstructive jaundice. 
Complete morphological and cytogenetic remission was 
obtained 4 weeks after the first cycle of chemotherapy 
(half dose of daunorubicin and full dose of cytarabine, 
treated off trial) on control bone marrow. the patient 
remains in remission.
BaCkground 
Acute myeloid leukaemia (AML) rarely presents 
with obstructive jaundice. A cholestatic picture 
in the context of AML is sometimes associated 
with chemotherapy.1 There are case reports of 
AML presenting as cholestatic jaundice as a result 
of hepatic sinusoidal infiltration, which usually 
resolves following cessation of chemotherapy.2 This 
case was an unusual presentation with large duct 
strictures, with no evidence of small duct obstruc-
tion or sinusoidal infiltration at liver biopsy.
Patients identified from previous case reports 
have presented with features suggesting a haema-
tological diagnosis, such as anaemia, lymphadenop-
athy and splenomegaly. In this case, the presenting 
symptoms were of obstructive jaundice, with no 
overt features of AML, and circulating blasts were 
initially undetectable in peripheral blood samples at 
presentation.
CaSe preSenTaTion
A 17-year-old man with no significant past medical 
history presented to the clinic with a 2-week history 
of worsening jaundice, lethargy, anorexia and 
progressive right upper quadrant abdominal pain. 
History revealed no recreational drug use, herbal 
remedies or supplements, and there was no history 
of high-risk sexual behaviour or recent foreign 
travel.
Clinical examination showed marked jaundice 
without ascites, liver flap or stigmata of chronic 
liver disease. There was no palpable lymphadenop-
athy and evidence of hepatosplenomegaly.
He was admitted 1 week later with progressive 
right upper quadrant abdominal pain and deterio-
rating liver function tests.
inveSTigaTionS
On first presentation, full blood count (FBC), 
differential cell count and clotting were normal. His 
liver function tests showed a mixed cholestatic and 
hepatitic picture with raised bilirubin 101 µmol/L, 
alkaline phosphatase (ALP) 311 U/L, alanine trans-
aminase (ALT) 536 IU/L, gamma-glutamyl trans-
ferase 446 IU/L and albumin 48 g/L. Serological 
testing for hepatitis A, B, C and E viruses, cyto-
megalovirus and Epstein–Barr virus was negative. 
Anti-nuclear antibodies (ANA), anti-neutrophil 
cytoplasmic antibodies, anti-smooth muscle anti-
bodies and anti-mitochondrial antibodies were all 
negative. Immunoglobulins were normal. Abdom-
inal ultrasound demonstrated a thick-walled and 
mildly dilated common bile duct (CBD) suggesting 
cholangitis, with intrahepatic bile duct dilatation 
(figure 1). The liver was smooth in outline and of 
normal echogenicity and the spleen was of normal 
size. Magnetic resonance cholangiopancreatog-
raphy (MRCP) confirmed significant intrahepatic 
biliary duct dilatation lying proximal to a hilar stric-
ture associated with soft tissue thickening as well 
as a CBD stricture and narrowing of the pancreatic 
duct (figure 2).
Two weeks after the first presentation, he devel-
oped a mild leukocytosis on FBC showing a total 
white count 8.6 x109/LL, haemoglobin concentra-
tion 138 g/L, platelet count 341 x109/L and mean 
corpuscular volume (MCV) 81.0 fl. The differential 
count showed: neutrophils 2.2 x109/L, lympho-
cytes 6 x109/L, monocyte 0.0 x109/L, eosinophils 
0.0 x109/L and basophils 0.0 x109/L. A peripheral 
blood film was performed showing atypical and 
reactive lymphocytes (see figure 3). A second blood 
film was performed 2 days later, showing increasing 
numbers of atypical lymphoid cells, which looked 
more malignant and less reactive than those seen in 
the previous film.
Bone marrow aspirate was performed and was 
hypercellular and densely packed with medi-
um-size and large-size blasts with vacuolation (see 
figure 4). Immunohistochemical analysis of the 
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blast cells was positive for CD13, CD117 and myeloperoxidase. 
Chromosome and fluorescence in situ hybridization analysis 
showed a pericentric inversion of chromosome 16 and insertion 
of unknown material into the long arm of chromosome 4. This 
was consistent with a diagnosis of AML (WHO subtype inv[16]
[p13.1q22]; CBFB-MYH11).
CT of the thorax, abdomen and pelvis was performed during 
the first cycle of chemotherapy to rule out fungal infection 
while the patient was neutropenic and septic. This confirmed 
the diagnosis of intrahepatic stricture with no abnormal liver 
architecture and appearance. There were no masses or signifi-
cant lymphadenopathy.
Transjugular liver biopsy was performed following the first 
cycle of chemotherapy. An earlier biopsy was contraindicated 
by the obstructive jaundice and risk of bile leak. Examination 
of the portal tracts showed a mild, predominantly intrahepato-
cytic cholestasis and a mild chronic inflammatory cell infiltrate, 
which was lymphohistiocytic. There was no overt evidence of 
liver infiltration by acute myeloid leukaemia.
differenTial diagnoSiS
In a 17-year-old male patient, a number of differential diagnoses 
are to be considered when presenting with obstructive jaundice, 
right upper quadrant pain and lethargy.
The detailed history taken on admission reduced the likeli-
hood of any potential drug-induced liver injury. The viral hepa-
titic screen returned negative.
Septic cholangitis and choledocolithiasis were excluded by the 
absence of raised inflammatory markers, negative microbiology 
and absence of stones on MRCP.
ANA, cytoplasmic antineutrophil cytoplasmic antibodies 
(cANCA), perinuclea anti-neutrophil cytoplasmic antibodies 
(pANCA), anti-smooth muscle antibodies and anti-mitochon-
drial antibodies, as well as immunoglobulins, were negative.
The liver biopsy performed after the first cycle showed no 
evidence of autoimmune liver disease, such as autoimmune 
hepatitis, primary sclerosing cholangitis (PSC), primary biliary 
cirrhosis or IgG4 cholangitis.
Cholangiocarcinoma rarely presents in this age group, partic-
ularly in the absence of PSC. His CA19.9 marker was normal.
figure 1 Abdominal ultrasound: intrahepatic bile duct 
thickening. CBD, common bile duct.
figure 2 Magnetic resonance cholangiopancreatography prior to 
treatment: multifocal strictures with proximal hilar stricture.
figure 3 Blood film ×100 hydroxyethyl starch (HES): atypical 
lymphoid cells.
figure 4 Bone marrow ×100 hydroxyethyl starch (HES): densely 
packed large-size blasts with vacuolation.
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The diagnosis of AML was made and was felt to be extremely 
unlikely that the biliary pathology represented a separate 
malignancy.
TreaTmenT
The obstructive jaundice (bilirubin 251 µmol/L, ALP 829 U/L 
and ALT 605 IU/L) was treated by interventional radiology with 
percutaneous transhepatic cholangiogram (PTC) of right duct 
system with subsequent cholangiography confirming a complex 
hilar stricture with no cross filling into the right posterior 
sectoral or left duct systems. A CBD stricture was also noted. 
Biliary drainage was achieved by the insertion of a 10.2F internal/
external drain into the right duct system (figure 5). Cytological 
examination of the biliary fluid was not performed.
Following right ductal PTC, a fall in serum bilirubin (bilirubin 
134 µmol/L, ALP 721 U/L and ALT 432 IU/L) allowed initiation 
of chemotherapy with half dose daunorubicin to limit the hepa-
totoxicity and full dose of cytarabine. He had a further three 
cycles of high-dose cytarabine. The inv (16) chromosome abnor-
mality was considered a good risk and an allograft was not indi-
cated in the first remission.
After 3 weeks, serum bilirubin levels remained elevated 
(52 µmol/L), with persistent dilatation of the left duct system. 
Therefore, a left PTC with 10.2F internal/external drain was 
sited and the right-sided drain replaced (figure 6) once the 
neutrophil count had recovered.
ouTCome and follow-up
During the neutropenic phase, following the first cycle of 
chemotherapy, the bilateral PTCs were closed with internal 
drainage to mitigate the risk of sepsis. Despite this, the patient 
had two episodes of neutropenic sepsis with infection of the 
PTC drains. He responded well to antibiotics. The drains were 
changed regularly for 4 months, before being permanently 
removed following chemotherapy and radiological resolution of 
the biliary strictures.
Repeat bone marrow biopsy showed complete morpholog-
ical and cytogenetic remission 4 weeks after the first cycle of 
chemotherapy.
The patient remained in remission following 4 cycles of 
chemotherapy. Follow-up MRCP in January 2016 showed 
significant improvement of the CBD and pancreatic duct stric-
tures (figure 7) and normal liver function on his follow-up 
biochemistry.
At 2 years post diagnosis, there has been no relapse or progres-
sion on follow-up MRCP imaging and liver function tests 
remained normal.
figure 5 Cholangiogram: right percutaneous transhepatic 
cholangiogram drains.
figure 6 Cholangiogram: left and right percutaneous transhepatic 
cholangiogram drains.
figure 7 Post-treatment magnetic resonance 
cholangiopancreatography: resolution of multiple biliary duct strictures.
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diSCuSSion
Obstructive jaundice has only rarely been observed as the 
presenting feature of AML, and only with small duct cholestatic 
features.1 It has been described in case reports as resulting from 
granulocytic sarcoma and leukaemic infiltration of the liver.2 
This is the first reported case of AML presenting with large bile 
duct strictures. Although we could not confirm direct AML inva-
sion in the biliary tracts, there was a synchronous presentation 
of AML and biliary strictures and the strictures subsequently 
resolved with chemotherapy.
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learning points
 ► This is a rare case of acute myeloid leukaemia 
(AML) presenting with obstructive jaundice.
 ► No evidence of hepatic infiltration was found on liver biopsy.
 ► Early percutaneous transhepatic cholangiogram and relief 
of biliary obstruction facilitated chemotherapy, resulting in 
remission of AML and radiological resolution of common bile 
duct strictures.
 ► The patient is in sustained remission after four cycles 
of chemotherapy with significant improvement of the 
intrahepatic and pancreatic ductal stricture.
 ► AML should be considered in the differential diagnosis of 
biliary strictures.
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